JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skucas, A. P.
Right arrow Articles by Artru, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skucas, A. P.
Right arrow Articles by Artru, A. A.
Related Collections
Right arrow Neuroanesthesia
Right arrow Anesthetic Techniques

Anesth Analg 2006;102:882-887
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000196721.49780.85


NEUROSURGICAL ANESTHESIA

Section Editor:
David S. Warner

Anesthetic Complications of Awake Craniotomies for Epilepsy Surgery

Andrius P. Skucas, MD, and Alan A. Artru, MD

Department of Anesthesiology, University of Washington, School of Medicine, Seattle, Washington

Address correspondence and reprint requests to Andrius P. Skucas, MD, Department of Anesthesiology, Box 356540, University of Washington, School of Medicine, Seattle, WA 98195-6540. Address e-mail to askucas{at}u.washington.edu.


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Awake craniotomies are often performed for resection of epileptogenic foci close to vital areas of the brain. For awake craniotomies at our institution, propofol is infused during local anesthetic injection and craniotomy, spontaneous ventilation is preserved, and no endotracheal tube or laryngeal mask airway is used. Propofol is discontinued for language, motor, and/or sensory mapping and for electrocorticography. Patients are re-sedated with propofol for resection and closure. We performed a retrospective chart review of 332 propofol-based "asleep-awake-asleep" (AAA) techniques with unsecured airways and 129 general anesthesia with endotracheal intubation craniotomies for epilepsy surgery. We compared the incidence of intraoperative respiratory and hemodynamic complications and incidence of seizures, nausea, brain swelling, patient movement, bleeding, aspiration, air embolism, and death. Airway compromise was uncommon in AAA cases and although incidences of hypertension, hypotension, and tachycardia were statistically increased in AAA versus general anesthesia craniotomy, these were treated appropriately. In only one patient the use of our AAA technique may have contributed to a poor clinical outcome.


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Although most craniotomies are performed under general anesthesia (GA) with endotracheal intubation, for resection of an epileptogenic lesion close to vital areas of the brain (including those responsible for speech and motor activity), an "awake" craniotomy may be preferred. To permit mapping of language, motor, and/or sensory function and electrocorticography (ECoG), GA or sedation must be discontinued during testing periods. The benefits of the awake craniotomy technique in selected patients have been described as a) providing a more favorable outcome regarding postoperative language impairment (1), b) possibly improving seizure-free postoperative outcomes (1,2), c) possibly reducing hospital length of stay (1,3), and d) using fewer invasive monitoring devices (e.g., arterial lines, central venous lines, urethral catheters) (3). Patients subjectively tolerate awake craniotomies with a high rate of satisfaction (4).

At our institution, awake craniotomies for epileptogenic focus resection are performed with an unprotected airway. A uniform protocol used since 1993 entails deep sedation by propofol infusion for injection of local anesthetic and craniotomy. During this time, spontaneous ventilation is preserved and no endotracheal tube, laryngeal mask airway (LMA), or similar device is used. Sedation is discontinued for mapping of language, motor, and/or sensory function and for ECoG. Patients are then re-sedated for resection of the lesion and closure. Our propofol-based awake craniotomy technique was first described as a case series of 9 patients premedicated with fentanyl 50-100 µg and droperidol 1.25-2.5 mg (5). No complications were noted. Since that time we have simplified our management to using a propofol infusion as the sole sedative drug and avoiding premedications as much as possible. We continue to avoid the use of endotracheal intubation or LMA placement.

Commonly called the "asleep-awake-asleep" (AAA) technique for craniotomy, concerns have been raised in the anesthesia literature including the lack of a secured airway, poor patient cooperation, patients experiencing nausea or pain during the procedure, and others (1,4,6–11). We performed a retrospective chart review of AAA cases for epileptogenic focus resection at our institution to examine the incidence of intraoperative complications. A chart review of epileptogenic focus resection performed under GA with endotracheal intubation was performed for comparison.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
With institutional approval for a medical chart review, we examined anesthetic records, recovery room nursing notes, operative dictations, postoperative chart notes, and discharge summaries of surgeries for epileptogenic focus resection dating from February 1993 to January 2004. Medical records were collected based on case lists generated from Department of Anesthesiology Continuous Quality Improvement databases. These were compared to case lists from the Department of Neurological Surgery. Chart review noted respiratory, hemodynamic, and other complications.

Anesthetic management in the AAA group was as outlined above. In the lateral or semi-lateral position, patients received a propofol infusion for the "asleep" portions; discontinuation of propofol for the "awake" portions; no use of an endotracheal tube, LMA, or similar device; and spontaneous ventilation. Propofol was dosed as an initial IV bolus of 0.5 mg/kg, then subsequent bolus doses of 0.25 mg/kg until the desired level of sedation was achieved, followed by continuous infusion at 75-250 µg·kg-1·min-1. Room air was supplemented by oxygen 3-6 L/min via nasal prongs or facemask. Use of a nasal trumpet was a standard part of the AAA technique and was not considered a "secured airway." Anesthesia in the GA group was induced with one or more IV drugs (thiopental, propofol, lidocaine, and/or opioid), an endotracheal tube was inserted, the patient's lungs were ventilated mechanically, and anesthesia was maintained using a volatile anesthetic (isoflurane or sevoflurane in oxygen) supplemented with an IV drug (fentanyl, sufentanil, or remifentanil).

Airway/ventilation complications in AAA cases were defined as any maneuver beyond placement of an oral or nasal airway required to permit unobstructed breathing and/or adequate ventilation. Airway/ventilation complications in GA cases were defined as difficulty (>3 attempts by more than 2 anesthesia care providers) or inability to insert an oral endotracheal tube, or difficulty with ventilation once the patient was tracheally intubated. In both AAA and GA, moderate oxyhemoglobin desaturation was defined as Spo 2 91%-95% and severe oxyhemoglobin desaturation was defined as Spo 2 ≤90%. The proportion of cases with desaturation events was noted. Paco 2 was also noted for those cases in which arterial blood gas tensions were measured.

Hemodynamic complications included abnormal arterial blood pressure and heart rate. Hypertension was defined as systolic blood pressure more than 150 mm Hg, hypotension was defined as systolic blood pressure <90 mm Hg, tachycardia was defined as heart rate more than 110 bpm, and bradycardia was defined as heart rate <45 bpm. The proportion of cases with hemodynamic complications was noted.

Other complications noted were intraoperative seizures, new intraoperative neurologic deficits, nausea without vomiting, nausea with vomiting, patient movement, brain swelling, bleeding, local anesthetic toxicity, pulmonary aspiration, air embolism, and death. We also noted the frequency of re-do operations for both types of anesthetic technique versus first-time craniotomies and the frequency of invasive arterial blood pressure monitoring (i.e., insertion of a catheter into an artery, usually a radial artery).

Two-tailed unpaired Student's t-tests for data collected as means (age, obese weight, and Paco 2) and {chi}2 tests for data collected as proportions, were performed using GraphPad Prism (version 3.02 for Windows 98; GraphPad Software, San Diego, CA). A P value <0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Four-hundred-sixty-one records were reviewed. Awake craniotomies were performed in 332 cases and GA was used in 129. Table 1 demonstrates the demographic profile of the patients. A statistically significant but clinically unimportant difference was found between the study groups with respect to patient age. There were no statistically significant differences in underlying comorbidities except that a larger proportion of GA patients had mental retardation/developmental delay or psychiatric issues precluding cooperation with awake testing. A larger proportion of GA cases were re-do craniotomies as compared with AAA cases.


View this table:
[in this window]
[in a new window]
 
Table 1. Demographic Profile of AAA Cases Versus GA Cases

 

Airway/ventilation complications occurred in 6 AAA cases (1.8%). One required temporary closure of the craniotomy 2 h after incision for Spo 2<93% with subsequent oral endotracheal intubation (via fiberoptic bronchoscope) after induction of GA; the case was then resumed. The second case required placement of a LMA for Spo 2 88%. The third patient developed apnea after a remifentanil bolus was given in addition to propofol infusion; as a result of poor mask ventilation, a LMA was placed, nasal 2% lidocaine and transtracheal 4% lidocaine were applied, and a nasal endotracheal tube was placed (via fiberoptic bronchoscope). All three patients who required their airways to be secured were obese. The fourth incident resulted in a nasal airway being placed and attached to the anesthesia circuit for Spo 2 93% while the fifth incident had a similar management but with an endotracheal tube blindly placed through the nares to a position above the glottis (in both cases the patients continued to ventilate spontaneously); the latter patient was obese. The sixth case was complicated by intraoperative laryngospasm but the specific management was not noted (it was noted on the anesthetic record, however, that the patient did not require tracheal intubation.) All six of these incidents occurred before the awake testing portion of the case and, besides obesity, these patients did not have underlying diagnoses of asthma, tobacco use, obstructive sleep apnea, or other pulmonary disease. The single airway/ventilation issue in the GA group (0.8%) was the development of an endotracheal tube cuff leak in one patient. Air was replaced into the cuff eight times and the patient did not require reintubation. None of the GA cases had any other difficulty with ventilation or inability to intubate.

AAA cases had statistically significantly more frequent incidences of oxyhemoglobin desaturation, hypertension, hypotension, and tachycardia, and significantly higher levels of Paco 2 (Table 2). GA cases had a statistically significantly more frequent incidence of bradycardia (Table 2). There was more frequent use of invasive arterial blood pressure monitoring (54.3% versus 13.6%) in GA cases (Table 1). Incidences of other complications did not differ between AAA and GA (Table 2). There were no reported instances of local anesthetic toxicity, pulmonary aspiration, air embolism, or death.


View this table:
[in this window]
[in a new window]
 
Table 2. Intraoperative Respiratory and Hemodynamic Variables and Other Events

 

One significant complication occurring in the AAA group appeared to be related to the anesthetic technique. The patient was a 59-yr-old female who refused blood transfusion for religious reasons. After craniotomy and removal of the bone flap, marked dural swelling was noted (Paco 2 at that time was 52 mm Hg). Attempts were made to mask-ventilate the patient to decrease the Paco 2. Nonetheless, with dural opening there was a large transverse sinus tear with a resultant significant hemorrhage (postoperative hematocrit was 18%). Although she survived the hospitalization, extensive ischemia was noted in the left temporal region with persistent right-sided hemiparesis at the time of discharge.


    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Our center's protocol for AAA craniotomies using a propofol infusion began in 1991, when patients were premedicated with fentanyl and droperidol before starting the propofol infusion and benzodiazepine premedication was deferred to minimize respiratory complications and interference with ECoG (5). By 1993, the regimen was simplified so that use of all premedications was discontinued and a sole propofol infusion was the only sedative. Opioids were only administered at the end of a case and did not supplement the propofol infusion (with the exception of the described airway complication resulting from a remifentanil bolus). Various anesthetic regimens for AAA technique have been described (6,7,9–16). Our comfort with this protocol is in part a result of certain properties of propofol inherently useful for the AAA technique including ease of titration, rapid and smooth recovery, antiemetic properties (particularly useful in patients in whom an endotracheal tube or LMA is not used), a sedative effect that is more euphorigenic than neuroleptic in character, and a reduced incidence of intraoperative seizures (8,17,18).

In addition to uniform adherence to a propofol infusion without other sedative drugs, AAA craniotomies at our center are performed with no instrumentation of the airway besides placement of a nasal trumpet. Techniques described for more secure airway protection include endotracheal intubation and awakening without removal of the endotracheal tube (disallowing vocalization testing), extubation and reintubation with an endotracheal tube after testing, and methods using placement, extubation, and replacement of an LMA or cuffed oropharyngeal airway (7,8,14,19–21). Noninvasive positive pressure ventilation has also been described (22). In our series of patients with unsecured airways, airway compromise during AAA requiring urgent or emergent securing of the airway was relatively rare and occurred only in obese patients; there was no association with asthma, tobacco use, or obstructive sleep apnea. Only 3 of 332 AAA patients required airway control with an endotracheal tube or LMA, including one patient in whom remifentanil was used in addition to propofol (a departure from our usual protocol). Two other patients experiencing desaturations simply had nasal airway devices placed and connected to the anesthesia circuit with adequate oxygen saturations (previously described as a means of improving oxygenation with spontaneous breathing and with controlled ventilation by closing the mouth and applying pressure to the reservoir bag) (23). Obesity (body mass index >30 kg/m2) appeared to be a consistent risk factor that led to oxygen desaturations requiring a secure airway. There were no negative sequelae to patients who had respiratory complications. The GA group had no significant respiratory complications besides a slowly leaking endotracheal tube cuff.

Higher Paco 2 was more common in the AAA group, as would be expected in a population of sedated patients breathing spontaneously. Brain swelling was noted in only 2 of those 332 patients, and may have contributed, in one of those two patients, to the occurrence of a clinically significant hemorrhage with dural opening. In retrospect, that patient may have benefited by more definitive airway control to allow hyperventilation before dural opening.

Hypertension, hypotension, and tachycardia were more frequent in the AAA group. In most cases, recognition of these hemodynamic changes prompted initiation of appropriate treatment and in no cases did isolated hemodynamic variability result in negative sequelae to a patient. Bradycardia was relatively rare in both groups. Reports of combining a propofol infusion with a remifentanil infusion and clonidine suggest smoother hemodynamic conditions, although we believe that this benefit may not outweigh the risk of respiratory complications from the use of opioids (10,16).

Differences in incidence of intraoperative seizures were not statistically significant between the two groups. In the AAA group, half of the seizures were tonic-clonic seizures and half were focal seizures of one or two extremities. Half occurred during the asleep portion and half during awake testing. Eight seizures were so brief in duration that no treatment was administered. One seizure during awake testing was treated with a small propofol bolus, another with a midazolam bolus. None of these patients required their airways to be secured with an endotracheal tube or LMA.

In the AAA group, nausea without vomiting, nausea with vomiting, and patient movement were relatively rare and were managed without apparent difficulty. Patients did not receive prophylactic antiemetic medications although when nausea did occur, antiemetics were administered. The infrequent nausea in the AAA group is at least partially attributable to the antiemetic properties of propofol and the lack of opioid administration.

The incidence of complications when using our anesthetic technique is compared with those reported in previous studies in Table 3. Although direct comparisons of respiratory complications with the prospective trials are difficult to interpret because of small sample sizes, our rates compare favorably. One retrospective trial had less respiratory complications but did not separate complications by anesthetic protocol (24). In the Herrick et al. study (16), airway complications in the propofol group occurred when opioids were added. Berkenstadt et al. (10) noted a decrease in respiratory complications over time as they became accustomed to their anesthetic protocol; our frequency of complications did not vary significantly over a 12-year period. The highest rates of seizures and nausea occurred in predominantly opioid-based protocols (13). Our protocol had the highest rates of hypotension, although this variable was not examined in most trials.


View this table:
[in this window]
[in a new window]
 
Table 3. Comparison of Complication Incidences in Other Asleep-Awake-Asleep Studies

 

Limitations of this study relate to those inherent to a retrospective chart review. The quality of the data collected is limited to the accuracy of the original medical chart and an intraoperative complication that was not reported would not be reflected in this study. Data regarding securing of the airway, oxygen desaturations, Paco 2, and hemodynamic variations are considered more reliable in being reflected in the anesthetic record compared with other variables studied. Several other factors may have contributed to the less frequent incidence of many categories of complications during GA as compared with AAA. One factor may have been our preoperative anesthetic assessment of the patient and selection of GA in patients determined to not be good candidates for the AAA technique. Use of controlled mechanical ventilation during GA permits the patient to be hyperventilated to relieve brain swelling. Control of brain swelling, in turn, decreases the risk of tearing a cerebral vessel or sinus at the time of dural opening. Also, arterial catheters were placed in a larger proportion of GA patients and their use facilitates more frequent sampling of arterial blood for measurement of Paco 2. Despite a larger proportion of re-do craniotomies in the GA group, these interventions may have decreased risks associated with dural adhesions and other scarring resulting from previous surgeries.

In summary, in this series of 332 epilepsy patients who underwent a propofol-based AAA technique with an unsecured airway, there were relatively infrequent clinically significant complications. Only one serious complication appears to have been related to the anesthetic technique.

The authors thank Karen Posner, PhD, and John Campos, MA (Department of Anesthesiology, University of Washington, Seattle, Washington) and George Ojemann, MD (Department of Neurological Surgery, University of Washington, Seattle, Washington) for assistance in obtaining patient case lists.


    Footnotes
 
Accepted for publication September 21, 2005.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Sahjpaul RL. Awake craniotomies: controversies, indications and techniques in the surgical treatment of temporal lobe epilepsy. Can J Neurol Sci 2000;27 Suppl 1:S55–63.[Medline]
  2. Kanazawa O, Blume WT, Girvin JP. Significance of spikes at temporal lobe electrocorticography. Epilepsia 1996;37:50–5.[ISI][Medline]
  3. Taylor MD, Bernstein M. Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg 1999;90:35–41.[ISI][Medline]
  4. Danks RA, Rogers M, Aglio LS, et al. Patient tolerance of craniotomy performed with the patient under local anesthesia and monitored conscious sedation. Neurosurgery 1998;42:28–36.[ISI][Medline]
  5. Silbergeld DL, Mueller WM, Colley PS, et al. Use of propofol (Diprivan) for awake craniotomies: technical note. Surg Neurol 1992;38:271–2.[ISI][Medline]
  6. Manninen PH, Contreras J. Anesthetic considerations for craniotomy in awake patients. Int Anesthesiol Clin 1986;24:157–74.[ISI][Medline]
  7. Huncke K, Van de Wiele B, Fried I, Rubinstein EH. The asleep-awake-asleep anesthetic technique for intraoperative language mapping. Neurosurgery 1998;42:1312–7.[ISI][Medline]
  8. Tongier WK, Joshi GP, Landers DF. Use of the laryngeal mask airway during awake craniotomy for tumor resection. J Clin Anesth 2000;12:592–4.[ISI][Medline]
  9. Archer DP, McKenna JMA, Morin L, Ravussin P. Conscious-sedation analgesia during craniotomy for intractable epilepsy: a review of 354 consecutive cases. Can J Anaesth 1988;35:338–44.[Abstract/Free Full Text]
  10. Berkenstadt H, Perel A, Hadani M, et al. Monitored anesthesia care using remifentanil and propofol for awake craniotomy. J Neurosurg Anesthesiol 2001;13:246–9.[ISI][Medline]
  11. Costello TG, Cormack JR. Anaesthesia for awake craniotomy: a modern approach. J Clin Neurosci 2004;11:16–9.[ISI][Medline]
  12. Trop D. Conscious-sedation analgesia during the neurosurgical treatment of epilepsies: practice at the Montreal Neurological Institute. Int Anesthesiol Clin 1986;24:175–84.[ISI][Medline]
  13. Gignac E, Manninen PH, Gelb AW. Comparison of fentanyl, sufentanil, and alfentanil during awake craniotomy for epilepsy. Can J Anaesth 1993;40:421–4.[Abstract/Free Full Text]
  14. Sarang A, Dinsmore J. Anaesthesia for awake craniotomy: evolution of a technique that facilitates awake neurological testing. Br J Anaesth 2003;90:161–5.[Abstract/Free Full Text]
  15. Johnson KB, Egan TD. Remifentanil and propofol combination for awake craniotomy: case report with pharmacokinetic simulations. J Neurosurg Anesthesiol 1998;10:25–9.[ISI][Medline]
  16. Herrick IA, Craen RA, Gelb AW, et al. Propofol sedation during awake craniotomy for seizures: patient-controlled administration versus neurolept anesthesia. Anesth Analg 1997;84:1285–91.[Abstract]
  17. Herrick IA, Craen RA, Gelb AW, et al. Propofol sedation during awake craniotomy for seizures: electrocorticographic and epileptogenic effects. Anesth Analg 1997;84:1280–4.[Abstract]
  18. Smith I, White PF, Nathanson M, Gouldson R. Propofol: an update on its clinical use. Anesthesiology 1994;81:1005–43.[ISI][Medline]
  19. Hall HK, Baldwin M, Norris F. Succinylcholine drip during craniotomy. Anesthesiology 1959;20:65–70.[ISI][Medline]
  20. Fukaya C, Katayama Y, Yoshino A, et al. Intraoperative wake-up procedure with propofol and laryngeal mask for optimal excision of brain tumour in eloquent areas. J Clin Neurosci 2001;8:253–5.[ISI][Medline]
  21. Audu PB, Loomba N. Use of cuffed oropharyngeal airway (COPA) for awake intracranial surgery. J Neurosurg Anesthesiol 2004;16:144–6.[ISI][Medline]
  22. Yamamoto F, Kato R, Sato J, Nishino T. Anaesthesia for awake craniotomy with non-invasive positive pressure ventilation. Br J Anaesth 2003;90:382–5.[Abstract/Free Full Text]
  23. Weiss FR, Schwartz R. Anaesthesia for awake craniotomy. Can J Anaesth 1993;40:1003.[Medline]
  24. Blanshard HJ, Chung F, Manninen PH, et al. Awake craniotomy for removal of intracranial tumor: considerations for early discharge. Anesth Analg 2001;92:89–94.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Br J AnaesthHome page
J. Dinsmore
Anaesthesia for elective neurosurgery
Br. J. Anaesth., July 1, 2007; 99(1): 68 - 74.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skucas, A. P.
Right arrow Articles by Artru, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skucas, A. P.
Right arrow Articles by Artru, A. A.
Related Collections
Right arrow Neuroanesthesia
Right arrow Anesthetic Techniques


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press